Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19
- PMID: 32474039
- PMCID: PMC7255987
- DOI: 10.1016/j.jinf.2020.05.049
Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19
Abstract
Objectives: The CURB-65 is a severity score to predict mortality secondary to community acquired pneumonia and is widely used to identify patients who can be managed as outpatients. However, whether CURB-65 can be applicable to COVID-19 patients for the decision of outpatient treatment is still unknown.
Methods: We conducted a retrospective single-centre study assessing the performance of the CURB-65 to predict the risk of poor outcome, defined as the need for mechanical ventilation and/or death, among patients hospitalized for COVID-19. The association between the CURB-65 and the outcome was assessed by a univariable Cox proportional hazard regression model.
Results: A total of 279 patients were hospitalized between March 15th and April 14th, 2020. According to the CURB-65, 171 (61.3%) patients were considered at low risk (CURB-65 01), 66 (23.7%) at intermediate risk (CURB-65=2), and 42 (15.1%) had high risk of 30-day mortality (CURB-65 35). During the study period, 88 (31.5%) patients had a poor outcome. The CURB-65 was strongly associated with a poor outcome (Pfor linear trend <0.001). However, among patients with a CURB-65 of 01, thus considered at low risk, 36/171 (21.1%) had a poor outcome.
Conclusions: Our study suggests that the applicability of CURB-65 to guide the decision of inpatient or outpatient care is scarce, as it does not safely identify patients who could be managed as outpatients.
Keywords: COVID-19; CURB-65; Outpatient care; Risk factor.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest None of the authors declared any competing interest in link with the present study.
Figures
Comment on
-
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort.J Infect. 2020 Aug;81(2):e59-e61. doi: 10.1016/j.jinf.2020.04.020. Epub 2020 Apr 27. J Infect. 2020. PMID: 32353384 Free PMC article. No abstract available.
References
-
- Jennifer Tomlins, Fergus Hamilton, Samuel Gunning, Caitlin Sheehy, Ed Moran, Alastair MacGowan. Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort. J Infect. 2020 doi: 10.1016/j.jinf.2020.04.020. S0163445320302322. - DOI - PMC - PubMed
-
- Chalmers James D., Aran Singanayagam, Akram Ahsan R., Pallavi Mandal, Short Philip M., Gourab Choudhury. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax. 2010;65(10):878–883. doi: 10.1136/thx.2009.133280. - DOI - PubMed
-
- Metlay Joshua P., Waterer Grant W., Long Ann C., Antonio Anzueto, Jan Brozek, Kristina Crothers. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi: 10.1164/rccm.201908-1581ST. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous